This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Boehringer Ingelheim Io Canada Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Phil Gobeil: Innovator in Antibody Development
Introduction
Phil Gobeil is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work is characterized by a commitment to advancing medical science and improving patient outcomes.
Latest Patents
Phil Gobeil holds a patent for "FLT3 Agonist Antibodies and Uses Thereof." This innovative patent reflects his expertise in antibody technology and its applications in treating various diseases. He has 1 patent to his name, showcasing his contributions to the field.
Career Highlights
Phil is currently employed at Boehringer Ingelheim (Canada) Inc., a leading global pharmaceutical company. His role involves research and development, where he applies his knowledge to create effective therapeutic solutions. His work at Boehringer Ingelheim has positioned him as a key player in the biotechnology sector.
Collaborations
Throughout his career, Phil has collaborated with talented professionals, including Arif Jetha and Melissa Beilschmidt. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.
Conclusion
Phil Gobeil is a dedicated inventor whose work in antibody development has the potential to make a significant impact in the medical field. His contributions, particularly through his patent, highlight his commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile